ArticlePediatric research2026
Global landscape of juvenile dermatomyositis research: a bibliometric analysis.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundJuvenile dermatomyositis (JDM) is the most common and severe form of juvenile idiopathic inflammatory myopathy. We conducted a global mapping of the JDM scientific literature to assess publication trends, collaboration patterns, intellectual structure, and emerging priorities.
methodsWe identified English-language original articles on JDM published between 1976 and 2024 in the Web of Science Core Collection (Science Citation Index Expanded), limited to clinically relevant categories. Bibliometrix and VOSviewer were used to generate key bibliometric indicators. Disruption Index was applied to distinguish disruptive from consolidating work.
resultsA total of 1113 articles were published in 201 journals by 5626 researchers. Publication output peaked in 2024, with an annual growth rate of 7.8%. The United States produced the largest number of publications, whereas the United Kingdom achieved the highest time-normalized citation rate. Recent research has increasingly focused on immunological endotyping, myositis-specific antibodies (MSAs), disease activity indices, and registry-based studies. Disruption Index analysis showed that disruptive contributions clustered around epidemiologic baselines, core outcome sets, treatment strategies, and clinical definitions.
conclusionJDM research has evolved into a measurement-driven, collaborative field focused on immunological profiling and standardized assessment. Strengthening international networks and registry-based designs may further accelerate progress in this rare disease domain. IMPACT: This study presents a comprehensive bibliometric analysis of juvenile dermatomyositis research spanning nearly five decades. The study identifies key publication trends, intellectual structures, and disruptive contributions shaping the field. The findings demonstrate that international collaboration and standardization efforts significantly enhance citation impact and field-wide influence. The study provides a strategic roadmap for future research, emphasizing endotype-based classification, registry integration, and cross-specialty dissemination to accelerate progress in this rare disease.
Identifiers
41803247What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.